Myasthenia Gravis Clinical Trial
Official title:
Univent Tube for Thoracoscopic Thymectomy in Myasthenic Patients: an Observational Study
NCT number | NCT06101407 |
Other study ID # | ÐHYHN168 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | January 15, 2016 |
Est. completion date | December 25, 2019 |
Verified date | October 2023 |
Source | Vietnam Military Medical University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This observational study included consecutive MG patients who underwent thoracoscopic thymectomy with Univent tube intubation under general anesthesia without NMBAs and combined with airway topical anesthesia between January 2016 and December 2019. The investigators focus on intubation conditions, surgical conditions, intraoperative respiratory, and airway complications
Status | Completed |
Enrollment | 83 |
Est. completion date | December 25, 2019 |
Est. primary completion date | December 20, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 15 Years to 80 Years |
Eligibility | Inclusion Criteria: - Myasthenia gravis patients - Undergoing thoracoscopic thymectomy - Undergoing general anesthesia Exclusion Criteria: - Mallampati IV - Surgical complications |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Nguyen Dang Thu | Hanoi Medical University |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Rate of laryngoscopy difficulty | Laryngoscopy difficulties are categorized as:
easy fair difficult |
During surgery | |
Primary | Rate of vocal cord position | Vocal cord positions are categorized as:
abducted intermediate/moving closed |
During surgery | |
Primary | Rate of reaction to tracheal tube insertion and cuff inflation | Reaction to tracheal tube insertion and cuff inflation are evaluated based on diaphragmatic movement/coughing and categorized as:
none slight vigorous/sustained |
During surgery | |
Primary | Rate of intubation conditions | Intubation conditions are categorized as:
excellent good poor |
During surgery | |
Primary | Neuromuscular transmission at intubation time. | Neuromuscular transmission was measured using TOF value (%) at intubation time. | During surgery | |
Primary | Rate of lung collapse | During the surgical procedure, After opening the pleura and directly examining the quality of lung collapse as follows:
- spontaneous - assisted with suction - manual |
During surgery | |
Primary | Rate of surgical conditions | The surgical conditions, as evaluated by surgeons and categorized as:
- excellent (complete collapse with perfect surgical exposure) - fair (total collapse, but the lung still has residual air) - poor (no collapse or partial collapse with interference in surgical exposure) |
During surgery | |
Secondary | Rate of vocal cord injuries | classified as:
redness edema hematoma |
After anesthesia emergence and up to 3-day post-surgeries or until complete resolution. | |
Secondary | Rate of bronchial injuries | classified as:
redness edema hematoma |
After anesthesia emergence and up to 3-day post-surgeries or until complete resolution. | |
Secondary | Rate of postoperative sore throat | Sore throat was defined as continuous throat pain (yes or no). | After anesthesia emergence and up to 3-day post-surgeries or until complete resolution. | |
Secondary | Rate of postoperative hoarseness | Hoarseness was categorized as a change in acoustic quality from the patient's previous voice (yes or no) | After anesthesia emergence and up to 3-day post-surgeries or until complete resolution. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05039190 -
Evaluate the Efficacy and Safety of HBM9161(HL161)Subcutaneous Injection in Patients With Generalized MG Patients
|
Phase 3 | |
Recruiting |
NCT04561557 -
Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System
|
Early Phase 1 | |
Completed |
NCT01727193 -
The Efficacy and Safety of Leflunomide or Azathioprine Therapy in Myasthenia Gravis Patients After Expand Thymectomy
|
Phase 3 | |
Completed |
NCT00285350 -
Mycophenolate Mofetil in Myasthenia Gravis
|
Phase 3 | |
Recruiting |
NCT05890833 -
The Risk of Falls Index for Patients With Neuromuscular Disorders
|
||
Completed |
NCT05694234 -
Influences of Sugammadex on Postoperative Progress in Patients With Myasthenia Gravis Undergoing Video-assisted Thoracoscopic Thymectomy: Retrospective Study
|
||
Recruiting |
NCT05635266 -
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
|
||
Not yet recruiting |
NCT04965987 -
Oxaloacetate in Myasthenia Gravis
|
Phase 1 | |
Not yet recruiting |
NCT05095103 -
Immune Profiles in Myasthenia Gravis
|
||
Completed |
NCT02066519 -
Benefits and Tolerance of Exercise in Patients With Generalized and Stabilized Myasthenia Gravis
|
N/A | |
Completed |
NCT02774239 -
A Pilot Trial To Assess The Feasibility And Efficacy Of SCIG In Patients With MG Exacerbation (SCIG-MG)
|
Phase 3 | |
Terminated |
NCT02102594 -
Therapy of Antibody-mediated Autoimmune Diseases by Bortezomib (TAVAB)
|
Phase 2 | |
Completed |
NCT02118805 -
Innovative Measures of Speech and Swallowing Dysfunction in Neurological Disorders
|
||
Terminated |
NCT01828294 -
Subcutaneous Ig Maintenance Therapy for Myasthenia Gravis
|
Phase 1 | |
Terminated |
NCT00727194 -
Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis
|
Phase 2 | |
Completed |
NCT04590716 -
Help Build an A.I. Model to Predict Myasthenia Gravis Symptom Patterns and Flares
|
||
Recruiting |
NCT04837625 -
Study of Myasthenic Crisis in China
|
||
Not yet recruiting |
NCT01469858 -
Perception and Multisensory Integration in Neurological Patients Using fMRI
|
N/A | |
Completed |
NCT05408702 -
Exercise in Autoimmune Myasthenia Gravis and Myasthenic Syndromes
|
||
Completed |
NCT03205306 -
Myasthenia Gravis and Psyche
|